Oral bioavailability enhancement of raloxifene with nanostructured lipid carriers
10.3390/nano10061085
Saved in:
Main Authors: | Murthy, A., Ravi, P.R., Kathuria, H., Malekar, S. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/198188 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
by: Das, S., et al.
Published: (2014) -
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles
by: Das, S., et al.
Published: (2014) -
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations
by: Das, S., et al.
Published: (2014) -
Formulation and Physicochemical Properties of Nanostructured Lipid Carriers from Beeswax and Rosemary oil as a Drug Carrier
by: Farhanim Mohd Latif, et al.
Published: (2020) -
Alendronate, raloxifene and tibolone inhibit the proliferation-stimulating activity of 17(beta)-estradiol in MCF-7 cells
by: N. Sookvanichsilp, et al.
Published: (2010)